v3.25.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Income Statement [Abstract]        
Net revenues $ 78 $ 68 $ 124 $ 127
Costs and operating expenses:        
Cost of goods sold 234 245 460 398
Research and development 2,485 2,591 5,233 4,951
Sales and marketing 361 497 719 822
General and administrative 2,068 1,587 3,889 3,691
Total costs and operating expenses 5,148 4,920 10,301 9,862
Operating loss (5,070) (4,852) (10,177) (9,735)
Other income (expense):        
Change in fair value of forward purchase agreement put option liability 103
Change in fair value of forward purchase agreement warrant liability 37 244 458 (18)
Change in fair value of publicly traded warrant liability (32) 801 162 (376)
Interest expense, related party (624) (132) (1,119) (168)
Other expense, net (1) (8) (12) (23)
Total other income (expense), net (620) 905 (511) (482)
Net loss (5,690) (3,947) (10,688) (10,217)
Cumulative preferred dividends (1,252) (1,365) (2,490) (2,730)
Net loss attributable to common stockholders, basic (6,942) (5,312) (13,178) (12,947)
Net loss attributable to common stockholders, diluted $ (6,942) $ (5,312) $ (13,178) $ (12,947)
Net loss per share attributable to common stockholders, basic (in Dollars per share) $ (0.32) $ (0.29) $ (0.62) $ (0.7)
Net loss per share attributable to common stockholders, diluted (in Dollars per share) $ (0.32) $ (0.29) $ (0.62) $ (0.7)
Weighted-average outstanding, basic (in Shares) 21,383,852 18,599,982 21,355,388 18,599,982
Weighted-average outstanding, diluted (in Shares) 21,383,852 18,599,982 21,355,388 18,599,982
Other comprehensive income (loss):        
Foreign currency translation adjustment $ (2) $ (1) $ 4 $ (2)
Other comprehensive income (loss) (2) (1) 4 (2)
Comprehensive loss $ (5,692) $ (3,948) $ (10,684) $ (10,219)